Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-05-31
1992-08-18
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 89, 514 91, 514 92, 514 94, 514171, 514212, 514218, 5142235, 514249, 514255, 514278, 514318, 514338, 514343, 514409, 514422, 514423, 514533, 514616, 514693, A61K 3702, C07K 506
Patent
active
051400120
ABSTRACT:
A method is provided for preventing or reducing the risk of restenosis following angioplasty by administering pravastatin alone or in combination with an ACE inhibitor such as captopril or ceranapril, prior to, during and/or after angioplasty.
REFERENCES:
patent: 4346227 (1982-08-01), Terahara et al.
Gellman, J. et al., "Lovastatin, a HMG CoA Reductase Inhibitor, Reduces Restenosis Following Balloon Angioplasty in an Atherosclerotic Hypercholesterolemic Rabbit", Clinical Research, vol. 37, No. 2, 1989, p. 261A.
Clin. Res. 36, 1988: 259A.
Clin. Invest 83, 1985: 1419.
Clin. Res. 37, 1989: 286A.
Sahni, R. et al., "Prevention of Restenosis by Lovastatin", 62nd Scientific Sessions of the American Heart Assoc., New Orleans, Nov. 13-16, 1989, Circulation 80 (4 Suppl. 2) 1989, p. II-65.
Gellman, J. et al., "Lovastatin, a HMG CoA Reductase Inhibitor, Reduces Restenosis Following Balloon Angioplasty in an Atherosclerotic Hypercholesterolemic Rabbit", Clinical Research, vol. 37, No. 2, 1989, p. 261A.
Powell, J. S. et al., "Inhibitors of Angiotension-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury", Science, vol. 245, 186-188, Jul. 14, 1989.
Chobanian, A. V. et al., "Antiatherogenic Effect of Captopril in the Watanabe Heritable Hyperlipidemic Rabbit", Hypertension, vol. 15, No. 3, Mar. 1990, pp. 327-331.
McGovern Mark E.
Ondetti Miguel A.
Pan Henry Y.
E. R. Squibb & Sons Inc.
Lee Lester L.
Rodney Burton
LandOfFree
Method for preventing onset of restenosis after angioplasty empl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing onset of restenosis after angioplasty empl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing onset of restenosis after angioplasty empl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249156